Latest News about LILLY DRN
Recent news which mentions LILLY DRN
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
From CNBC.com News
5 things to know before the stock market opens Friday
December 20, 2024
From CNBC.com News
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
December 19, 2024
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
December 04, 2024
From CNBC.com News
5 things to know before the stock market opens Tuesday
November 26, 2024
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
November 26, 2024
From CNBC.com News
From CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
November 18, 2024
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
From CNBC.com News
From CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
November 09, 2024
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
From CNBC.com News
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
October 30, 2024
From CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
October 30, 2024
From CNBC.com News
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
From CNBC.com News
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
From CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
October 23, 2024
From CNBC.com News
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
From CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
October 21, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.